Vials with a sticker reading "COVID-19 / Coronavirus vaccine / Injection only" and a medical syringe are seen in front of a displayed Pfizer logo in this illustration taken on October 31, 2020. (Reuters photo)

Johnson & Johnson is facing unexpected delays in the manufacturing of its coronavirus vaccine and may not be able to supply the doses it promised the federal government by spring, the New York Times reported on Wednesday.

US federal officials have been told that J&J has fallen as much as two months behind the original production schedule and will not catch up until the end of April, when it was supposed to have delivered more than 60 million doses, the NYT reported, citing people familiar with the situation.

The company and the US Department of Health and Human Services did not immediately respond to Reuters requests for comment.

Earlier this week, J&J�s chief executive officer said the company was on track to have close to a billion COVID-19 vaccine doses by 2021-end.

(Source: Reuters)

LINK: https://www.ansarpress.com/english/22003

*	NAME
*	COMMENT
4 DIGITS BELOW
*

	�UK national scandal�: 20,000 mental health patients �raped, sexually assaulted� in NHS care
	US: 3 dead in shooting at Texas apartment complex
	UN agency says over half a million Palestinians face �catastrophic hunger� in Gaza
	Survivors of Russian charter flight crash transferred to Kabul
	Pro-Israel lobby ousted ABC journalist, prompting staff to call for industrial action
	UNICEF: Afghan earthquakes leave 100,000 children in urgent need of aid this winter
	Thousands rage in Toronto against Israeli genocide as Gaza war marks 100 days
	Thousands rally in front of White House to demand ceasefire in Gaza
	Increased Taliban arrests lead to Kabul families restricting women�s movement
	Taliban arrests dozens of women in Kabul for �improper hijab,� says women�s group